e R i a X e n : i m p i f h. It has been hypothesized that decreased fertility and increased sexual dysfunction in wildlife are associated with endocrine-related toxicants (1, 2) . For example, fish exposed to various endocrine-mimicking compounds (e.g., TCDD, polychlorinated biphenyls, or o,p'-DDT) exhibit smaller gonads, reduced egg output, abnormal plasma sex hormone concentrations, and greater embryonic mortality (3, 4) . Various xenoestrogens, such as o,p'-DDT (5) and octyl phenol (OP) (6) (7, 8) . It has been hypothesized that the effects observed in wildlife exposed to xenoestrogens could serve as biomarkers for public health (1,2>9).
Endocrine signaling is a complex process involving synthesis, release, uptake, and the eventual degradation of hormones. The physiological response generated in the target cell due to a hormone is a composite of these processes. Thus, the effective concentration is that concentration capable of inducing a specific response in the target cell and, in the case of estradiol, is modified by binding to serum proteins such as albumin and sex hormone binding globulin (SHBG). Albumin is a nonspecific binding protein with a low affinity and specificity for estradiol, whereas SHBG has a high affinity and specificity for estradiol. The synthetic estrogen diethylstilbestrol (DES) has been shown to have a much lower affinity for SHBG than estradiol.
Therefore, at equivalent concentrations of estradiol and DES, the concentration of DES at the target cell will be significantly greater than that of estradiol.
Recent studies examining a number of wildlife species have demonstrated that exposure to contaminants can permanently modify the embryonic development of the reproductive and endocrine systems (2) . One well-documented case is that of the alligators living in Lake Apopka, Florida. The alligators were exposed to a number of anthropogenic contaminants derived from agricultural and municipal activity as well as a major pesticide (dicofol and DDT) spill (10) (11) (12) . Alligator eggs from Lake Apopka show elevated levels of p,p'-DDE, p,p'-DDD, dieldrin, and various polychlorinated biphenyls (PCBs) (13) . Hatchlings from these eggs exhibited abnormal gonadal anatomy, gonadal steroidogenesis, and plasma sex steroid concentrations (11, 12) . Recent data suggest that the abnormalities in plasma sex-steroid concentrations are partly due to modifications in the serum binding capabilities for the various sex steroids (12) . Variations in serum binding will modify circulating sex steroid levels and will also modify the transport and cellular availability of various xenoestrogens. Although serum binds naturally occurring sex steroids, it does not appear that serum proteins interact, to any great extent, with synthetic estrogens, such as DES (14) or with environmental estrogens such as op'-DDT (15) .
In order to measure the estrogenicity of a certain compound, several factors must be taken into account: 1) affinity of the compound for the estrogen receptor, 2) accumulation of the compound in the environment and the body, 3) degradation or metabolism of the compound in the envi-Articles -Yeast estrogen screen ronment and body, and 4) the availability of the compound to the target cell. The Escreen assay has been developed to identify environmental compounds that demonstrate estrogenicity (16, 17) . This assay uses the proliferation of MCF7 breast carcinoma cells as a marker of estrogenicity. We created a simpler approach, the yeast estrogen screen (YES), using a yeast strain responsive to estrogens. Yeast do not contain sex steroid or thyroid hormone receptors, except those transfected into the strain, but they possess proteins homologous to mammalian cells that are required for activated transcription. In this paper, we present the use of the YES system for the screening of xenoestrogens. In addition, the YES system was used to assess the relative bioavailability of estradiol compared to the synthetic estrogens DES, o,p'-DDT, and OP.
Materials and Methods
We purchased 17,-estradiol, DES, o,p'- Samples were collected from the brachial blood vessels and treated as described above. Before use in the YES system, serum was charcoal-stripped by incubation with 5% Norit-A overnight at 40C. The serum was separated from the charcoal by centrifugation and the protein concentration determined using the Bio-Rad (Hercules, California) protein assay. The protein concentration of the alligator serum was 70 mg/ml and of the human serum was 55 mg/ml. The inclusion of albumin, SHBG and sera from human and alligator at the concentrations used did not significantly affect the growth of the yeast.
For the ,B-galactosidase assays, the yeast cells were collected by centrifugation and resuspended in 700 ml of Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 35 mM P-mercaptoethanol). The cells were permeabilized by the addition of 6 ml of CHCl3 and 4 ml of 0.1% sodium dodecyl sulfate followed by vortexing for 25 sec. The reactions were equilibrated at 30°C for 10 min, then 160 ml ONGP (4 mg o-nitrophenyl ,B-D-galactopyranoside/ml Z-buffer) was added and the reactions returned to 30°C. The reactions were terminated by the addition of 400 ml IM NaCO3, the cell debris was removed by centrifugation at 15,000g for 5 min, and the absorbance (A) at 420 nm was measured. Miller units were determined using the following formula:
[A420/(A600 of 1 (Fig. 3) .
Normal serum albumin levels in adult males and females average 45 mg/ml and 41 mg/ml, respectively (19) . A doseresponse curve with various concentrations of albumin indicated that the IC 0 (the concentration required to inhibit 3-galactosidase activity by 50%) was 12.5 mg/ml. Albumin was a less effective inhibitor of jgalactosidase activity in the presence of DES, o>p'-DDT, and OP, with an IC50 of approximately 100 mg/ml. Albumin was 1.7-fold more effective in reducing 3-galactosidase activity in the presence of estradiol compared to DES, o,p'-DDT, and OP. SHBG was significantly more effective than albumin in reducing ,B-galactosidase activity. The IC50 for SHBG was 0.035 mg/ml for estradiol, 0.15 mg/ml for DES, o,p'-DDT, and 0.1 mg/ml for OP (Fig. 4) . Normal serum concentrations of SHBG in nonpregnant females and males range from 0.003-0.015 mg/ml (20 (24) , when the serum used was obtained. However, the concentration of SHBG in alligator serum was comparable to that reported for human serum (20, 24) . As far as we know, only one report exists on the concentration of SHBG in alligators (24) , and therefore this area awaits further research. The differences in response could be due to either seasonal variation in serum protein composition or to species-specific differences in serum protein composition rather than to the absence of sex hormone binding proteins in alligators.
It is important to note that the IC50 values for human and alligator sera with 17,-estradiol were approximately equivalent. This leads us to conclude that the differences in serum binding with xenoestrogens is due to species-specific differences in serum protein composition. Nevertheless, our data suggest that a bioassay could be developed to measure the sensitivity of a species to xenoestrogens by testing a species' serum for binding activity in the YES system. Use of whole serum from various species would provide data on interspecies variation in the potential bioavailability of xenoestrogens. With respect to the alligator, whole serum rather than the individual binding proteins was used because the identification and characterization of binding proteins has been very limited (24) . Importantly, it is the binding characteristics of whole serum, not a single plasma protein, that will define the bioavailability of xenoestrogens. This information, coupled with data on the capacity of the estrogen receptor to recognize specific xenoestrogens, and the concentrations of various xenoestrogens in a species' environment, could be predictive of potential health risks.
The impact of xenoestrogens on the health of humans and wildlife will require identifying the differences between natural estrogens and xenoestrogens. Several distinctions between natural estrogens and xenoestrogens are beginning to emerge. Data to date indicate that xenoestrogens are metabolized at a significantly slower rate than estradiol, suggesting that xenoestrogens may accumulate in lipids or persist in serum to concentrations sufficient to activate the estrogen receptor. In addition, slower metabolism may account for the increased nuclear retention of the estrogen receptor after binding xenoestrogens compared to estradiol. As shown in this study, the bioavailability of xenoestrogens in serum is apparently greater than that of estradiol.
In conclusion, the YES system can be used to identify and characterize xenoestrogens. The xenoestrogens tested have greater bioavailability in serum than estradiol, indicating a fundamental difference between natural estrogens and some xenoestrogens. We hypothesize that increased availability of xenoestrogens in serum would lead to a greater response at the cellular level. The difference in the ability of human and alligator serum to bind xenoestrogens may indicate that a species-specific sensitivity to xenoestrogens exists. In addition, future studies need to be performed on the binding affinity of the estrogen receptor from various species for the xenoestrogens found in their environment. For as we have proposed, the estrogenicity of various xenoestrogens depends on their availability, metabolism, and binding affinity to the estrogen receptor.
